WO2001057087A3 - Nouvelle proteine du type sous-unite beta de recepteur de haute affinite pour l'immunoglobuline epsilon (fceb) et acides nucleiques codant pour celle-ci - Google Patents

Nouvelle proteine du type sous-unite beta de recepteur de haute affinite pour l'immunoglobuline epsilon (fceb) et acides nucleiques codant pour celle-ci Download PDF

Info

Publication number
WO2001057087A3
WO2001057087A3 PCT/US2001/003564 US0103564W WO0157087A3 WO 2001057087 A3 WO2001057087 A3 WO 2001057087A3 US 0103564 W US0103564 W US 0103564W WO 0157087 A3 WO0157087 A3 WO 0157087A3
Authority
WO
WIPO (PCT)
Prior art keywords
fceb
subunit
protein
nucleic acids
high affinity
Prior art date
Application number
PCT/US2001/003564
Other languages
English (en)
Other versions
WO2001057087A2 (fr
Inventor
Debasish Raha
John Carruli
Richard L Cates
Original Assignee
Curagen Corp
Biogen Inc
Debasish Raha
John Carruli
Richard L Cates
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Biogen Inc, Debasish Raha, John Carruli, Richard L Cates filed Critical Curagen Corp
Priority to AU2001234797A priority Critical patent/AU2001234797A1/en
Publication of WO2001057087A2 publication Critical patent/WO2001057087A2/fr
Publication of WO2001057087A3 publication Critical patent/WO2001057087A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne de nouveaux polynucléotides de FCEB isolés et des polypeptides codés par les polynucléotides de FCEB. L'invention concerne aussi les anticorps qui se lient spécifiquement, d'un point de vue immunologique, à un polypeptide de FCEB et tout dérivé, variant, mutant ou fragment du polypeptide, du polynucléotide ou de l'anticorps de FCEB. L'invention concerne de plus des procédés dans lesquels un polypeptide, un polynucléotide et un anticorps de FCEB sont utilisés pour détecter et traiter une large gamme d'états pathologiques, et pour d'autres applications.
PCT/US2001/003564 2000-02-02 2001-02-02 Nouvelle proteine du type sous-unite beta de recepteur de haute affinite pour l'immunoglobuline epsilon (fceb) et acides nucleiques codant pour celle-ci WO2001057087A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001234797A AU2001234797A1 (en) 2000-02-02 2001-02-02 Novel high affinity immunoglobulin epsilon receptor beta-subunit-like protein and nucleic acids encoding same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17988300P 2000-02-02 2000-02-02
US60/179,883 2000-02-02

Publications (2)

Publication Number Publication Date
WO2001057087A2 WO2001057087A2 (fr) 2001-08-09
WO2001057087A3 true WO2001057087A3 (fr) 2002-02-07

Family

ID=22658379

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/003564 WO2001057087A2 (fr) 2000-02-02 2001-02-02 Nouvelle proteine du type sous-unite beta de recepteur de haute affinite pour l'immunoglobuline epsilon (fceb) et acides nucleiques codant pour celle-ci

Country Status (2)

Country Link
AU (1) AU2001234797A1 (fr)
WO (1) WO2001057087A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005481A1 (fr) * 1993-08-18 1995-02-23 Isis Innovation Limited Procede de diagnostic et therapie
US5807988A (en) * 1992-04-16 1998-09-15 The United States Of America As Represented By The Department Of Health And Human Services Isolation, characterization, and use of the human and subunit of the high affinity receptor for immunoglobulin E
WO1999062550A1 (fr) * 1998-06-04 1999-12-09 Michael Caplan Therapie anti-allergique pan-specifique

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807988A (en) * 1992-04-16 1998-09-15 The United States Of America As Represented By The Department Of Health And Human Services Isolation, characterization, and use of the human and subunit of the high affinity receptor for immunoglobulin E
WO1995005481A1 (fr) * 1993-08-18 1995-02-23 Isis Innovation Limited Procede de diagnostic et therapie
WO1999062550A1 (fr) * 1998-06-04 1999-12-09 Michael Caplan Therapie anti-allergique pan-specifique

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 4 February 1999 (1999-02-04), MARRA ET AL.: "High affinity immunoglobulin epsilon receptor bet-subunit", XP002177887 *
SUTTON B J ET AL: "The human IgE network", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 366, 2 December 1993 (1993-12-02), pages 421 - 428, XP000421323, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
AU2001234797A1 (en) 2001-08-14
WO2001057087A2 (fr) 2001-08-09

Similar Documents

Publication Publication Date Title
WO2000058473A3 (fr) Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx»
WO2001092523A3 (fr) Nouveaux polynucleotides humains et polypeptides codes par ceux-ci
WO2003000842A3 (fr) Nouvelles proteines et acides nucleiques codant pour de telles proteines
WO2004048521A3 (fr) Composition et procede pour traiter la nephropathie lupique
WO2001036645A3 (fr) Nouveaux polypeptides et acides nucleiques codant les memes
WO2002081498A3 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002066647A3 (fr) Recepteur de cytokine de type 2 et acides nucleiques codant ce recepteur
WO2000053742A3 (fr) Polynucleotides et proteines codees par ceux-ci
WO2001049729A8 (fr) Nouveaux polypeptides et acides nucleiques codant ceux-ci
WO2001074856A3 (fr) Polypeptides de type wnt-7b et acides nucleiques codant pour ceux-ci
WO2003010327A3 (fr) Nouvelles proteines et acides nucleiques les codant
WO2001062928A3 (fr) Polypeptides et acides nucleiques codant pour
WO2001070978A3 (fr) Nouveaux polypeptides et acides nucleiques codant ces polypeptides
WO2002002625A3 (fr) Nouveaux facteurs de croissance des fibroblastes et acides nucleiques codant pour ces memes facteurs
WO2001061009A3 (fr) Nouveaux polypeptides et acides nucleiques les codant
WO2003025147A3 (fr) Nouveaux polynucleotides et proteines codees par ceux-ci
WO2001044473A3 (fr) Polypeptides et acides nucleiques codant pour ces polypeptides
WO2001036638A3 (fr) Nouveaux polypeptides et acides nucleiques codant pour ces polypeptides
WO2002072757A3 (fr) Proteines et acides nucleiques codant pour ces proteines
WO2000061754A3 (fr) Nouvelles proteines humaines et polypeptides codant pour ces proteines
WO2003040345A3 (fr) Recepteur de cytokine de type 2 et acides nucleiques codant ce dernier
WO2001068851A3 (fr) Nouveaux polypeptides et acides nucleiques les codant
WO2000070046A3 (fr) Nouveaux polypeptides et polynucleotides les codant
WO2001023561A3 (fr) Nouveaux polynucleotides codant des proteines contenant des sequences repetees de thrombospondine type 1 (tsrx)
WO2001032874A3 (fr) Nouveaux polypeptides et acides nucleiques les codant

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP